文献速递白血病淋巴瘤

T细胞急性淋巴细胞白血病中MYB调控的转录调控程序

Transcriptional regulatory program controlled by MYB in T-cell acute lymphoblastic leukemia.
PubMed 文献 · Leukemia · 2024-11-02

该研究探讨转录因子MYB在T细胞急性淋巴细胞白血病(T-ALL)中的核心作用,发现长亚型ENST00000367814.8优势表达并赋予增殖优势,dTAG介导的MYB快速降解可区分早期应答基因与晚期应答基因,后者持续下调并影响细胞表型。

要点

  • MYB在T-ALL中频繁上调,其长亚型ENST00000367814.8优势表达并赋予T-ALL细胞增殖优势。
  • dTAG介导MYB快速降解后,早期应答基因包括TAL1、RUNX1、GATA3、IKZF2、CXCR4等造血相关基因,其表达后期可恢复,提示负反馈环路机制。
  • 晚期应答基因在MYB降解后持续下调,包括许多细胞增殖相关基因及TAL1靶基因,从而影响细胞表型。

核心结论

  • MYB通过调控T-ALL发病必需基因发挥关键作用,其长亚型ENST00000367814.8优势表达并赋予T-ALL细胞增殖优势。

研究设计与样本

  • 研究采用整合分析及dTAG介导的MYB快速蛋白降解体系,在T-ALL细胞中鉴定MYB调控的基因程序。

主要发现

  • 整合分析揭示长MYB亚型ENST00000367814.8在T-ALL细胞中优势表达并赋予增殖优势。
  • dTAG介导MYB快速降解影响大量基因,按动力学分为早期应答基因与晚期应答基因。
  • 早期应答基因包括TAL1、RUNX1、GATA3、IKZF2、CXCR4等造血相关基因,其表达在后期时间点可恢复,提示负反馈环路机制。
  • 晚期应答基因在MYB降解后持续下调,包括许多细胞增殖相关基因及TAL1靶基因,从而影响细胞表型。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The transcription factor MYB is frequently upregulated in T-cell acute lymphoblastic leukemia (T-ALL), a hematological malignancy originating from T-cell precursors. Here, we demonstrate that MYB plays a crucial role by regulating genes essential for T-ALL pathogenesis. Integrative analysis reveals a long MYB isoform, ENST00000367814.8, which is dominantly expressed and confers a proliferative advantage in T-ALL cells. Rapid depletion of MYB via dTAG-mediated protein degradation affects a large number of genes, which can be classified into early response or late response genes based on their kinetics. Early response genes include many genes involved in hematopoiesis, such as TAL1, RUNX1, GATA3, IKZF2, and CXCR4. Their expression can be recovered at later time-points, suggesting the presence of a negative feedback loop mechanism. In contrast, late response genes, which are continuously downregulated after MYB depletion, includes many genes involved in cell proliferation as well as TAL1 targets, thereby affecting the cellular phenotype.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Shao X, Yokomori R, Ong JZL, et al. Transcriptional regulatory program controlled by MYB in T-cell acute lymphoblastic leukemia. Leukemia. 2024. PMID: 39488662. doi:10.1038/s41375-024-02455-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。